1. Home
  2. NPKI vs ABCL Comparison

NPKI vs ABCL Comparison

Compare NPKI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$13.53

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.43

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
ABCL
Founded
1932
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NPKI
ABCL
Price
$13.53
$3.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$14.17
$7.75
AVG Volume (30 Days)
722.6K
2.9M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$14.60
N/A
Revenue Next Year
$12.80
$16.59
P/E Ratio
$38.65
N/A
Revenue Growth
N/A
160.56
52 Week Low
$4.76
$1.89
52 Week High
$15.85
$6.52

Technical Indicators

Market Signals
Indicator
NPKI
ABCL
Relative Strength Index (RSI) 44.55 46.24
Support Level $13.31 $3.37
Resistance Level $14.00 $3.84
Average True Range (ATR) 0.51 0.16
MACD -0.03 -0.00
Stochastic Oscillator 33.97 9.52

Price Performance

Historical Comparison
NPKI
ABCL

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: